ORCID as entered in ROS

Select Publications
Parker G; Tavella G; Ricciardi T; Hadzi-Pavlovic D, 2020, 'Differentiating clinical and non-clinical depression: a heuristic study offering a template for extension studies', Acta Psychiatrica Scandinavica, 141, pp. 340 - 349, http://dx.doi.org/10.1111/acps.13130
Parker G; Loo C, 2020, 'Temporal effects of bitemporal electroconvulsive therapy', Australian and New Zealand Journal of Psychiatry, 54, pp. 433 - 434, http://dx.doi.org/10.1177/0004867419889408
Martino DJ; Valerio MP; Parker G, 2020, 'The structure of mania: An overview of factorial analysis studies', European psychiatry : the journal of the Association of European Psychiatrists, 63, pp. e10, http://dx.doi.org/10.1192/j.eurpsy.2020.18
Bayes AJ; Parker GB, 2020, 'Differentiating borderline personality disorder (BPD) from bipolar disorder: diagnostic efficiency of DSM BPD criteria', Acta Psychiatrica Scandinavica, 141, pp. 142 - 148, http://dx.doi.org/10.1111/acps.13133
Boyce P; Hopwood M; Morris G; Hamilton A; Bassett D; Baune BT; Mulder R; Porter R; Parker G; Singh AB; Outhred T; Das P; Malhi GS, 2020, 'Switching antidepressants in the treatment of major depression: When, how and what to switch to?', Journal of Affective Disorders, 261, pp. 160 - 163, http://dx.doi.org/10.1016/j.jad.2019.09.082
Parker G, 2020, 'Australian psychiatrists on the world stage', Australian and New Zealand Journal of Psychiatry, 54, pp. 15 - 19, http://dx.doi.org/10.1177/0004867419864432
Porter RJ; Baune BT; Morris G; Hamilton A; Bassett D; Boyce P; Hopwood MJ; Mulder R; Parker G; Singh AB; Outhred T; Das P; Malhi GS, 2020, 'Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients', BJPsych Open, 6, pp. e40, http://dx.doi.org/10.1192/bjo.2020.17
Bayes A; Parker G; Paris J, 2019, 'Differential Diagnosis of Bipolar II Disorder and Borderline Personality Disorder', Current Psychiatry Reports, 21, http://dx.doi.org/10.1007/s11920-019-1120-2
Parker G, 2019, 'Do Changes in Employment Status Induce or "harvest" Suicides?', Journal of Nervous and Mental Disease, 207, pp. 1039 - 1044, http://dx.doi.org/10.1097/NMD.0000000000001099
Mulder R; Bassett D; Morris G; Hamilton A; Baune BT; Boyce P; Hopwood M; Parker G; Porter R; Singh AB; Das P; Outhred T; Malhi GS, 2019, 'Trying to describe mixed anxiety and depression: Have we lost our way?', Depression and Anxiety, 36, pp. 1122 - 1124, http://dx.doi.org/10.1002/da.22961
Parker G, 2019, 'How Well Does the DSM-5 Capture Schizoaffective Disorder?', Canadian Journal of Psychiatry, 64, pp. 607 - 610, http://dx.doi.org/10.1177/0706743719856845
Martino DJ; Szmulewicz AG; Valerio MP; Parker G, 2019, 'Melancholia: An Attempt at Definition Based on a Review of Empirical Data', Journal of Nervous and Mental Disease, 207, pp. 792 - 798, http://dx.doi.org/10.1097/NMD.0000000000001090
Bayes AJ; Parker GB, 2019, 'Cognitive and Behavioral Differentiation of Those With Borderline Personality Disorder and Bipolar Disorder', Journal of Nervous and Mental Disease, 207, pp. 620 - 625, http://dx.doi.org/10.1097/NMD.0000000000001024
Mohan A; Bayes A; Sachdev PS; Parker G; Mitchell PB, 2019, 'Junior clinical academic psychiatrists in Australia: The University of New South Wales initiative', Australasian Psychiatry, 27, pp. 241 - 244, http://dx.doi.org/10.1177/1039856218819135
Boschloo L; Bekhuis E; Weitz ES; Reijnders M; DeRubeis RJ; Dimidjian S; Dunner DL; Dunlop BW; Hegerl U; Hollon SD; Jarrett RB; Kennedy SH; Miranda J; Mohr D; Simons AD; Parker G; Petrak F; Herpertz S; Quilty LC; John Rush A; Segal ZV; Vittengl JR; Schoevers RA; Cuijpers P, 2019, 'The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis', World Psychiatry, 18, pp. 183 - 191, http://dx.doi.org/10.1002/wps.20630
Baune BT; Boyce P; Morris G; Hamilton A; Bassett D; Hopwood M; Mulder R; Parker G; Porter R; Singh AB; Outhred T; Das P; Malhi GS, 2019, 'Organising the front line: Is there a rationale for the first-line pharmacotherapy of major depressive disorder?', Australian and New Zealand Journal of Psychiatry, 53, pp. 279 - 281, http://dx.doi.org/10.1177/0004867418824026
Bayes A; Parker G, 2019, 'How to choose an antidepressant medication', Acta Psychiatrica Scandinavica, 139, pp. 280 - 291, http://dx.doi.org/10.1111/acps.13001
Parker G; Malhi GS, 2019, 'Persistent Depression: Should Such a DSM-5 Diagnostic Category Persist?', Canadian Journal of Psychiatry, 64, pp. 177 - 179, http://dx.doi.org/10.1177/0706743718814429
Bassett D; Parker G; Hamilton A; Morris G; Baune BT; Boyce P; Hopwood M; Mulder R; Porter R; Singh A; Outhred T; Mannie Z; Das P; Malhi GS, 2019, 'Treatment-resistant depressive disorders: The when, how and what of augmentation therapy', Australian and New Zealand Journal of Psychiatry, 53, pp. 187 - 189, http://dx.doi.org/10.1177/0004867419828483
Parker GB; Cvejic E; Vollmer-Conna U; McCraw S; Granville Smith I; Walsh WF, 2019, 'Depression and poor outcome after an acute coronary event: Clarification of risk periods and mechanisms', Australian and New Zealand Journal of Psychiatry, 53, pp. 148 - 157, http://dx.doi.org/10.1177/0004867418763730
Parker G; Ricciardi T, 2019, 'Mixed states in bipolar disorder: modelling, measuring and managing', Australasian Psychiatry, 27, pp. 69 - 71, http://dx.doi.org/10.1177/1039856218794883
Parker G; Tavella G; Hadzi-Pavlovic D, 2019, 'Identifying and differentiating melancholic depression in a non-clinical sample', Journal of Affective Disorders, 243, pp. 194 - 200, http://dx.doi.org/10.1016/j.jad.2018.09.024
Brunoni AR; Sampaio-Junior B; Moffa AH; Aparício LV; Gordon P; Klein I; Rios RM; Razza LB; Loo C; Padberg F; Valiengo L; Parker G, 2019, 'Noninvasive brain stimulation in psychiatric disorders: A primer', Revista Brasileira de Psiquiatria, 41, pp. 70 - 81, http://dx.doi.org/10.1590/1516-4446-2017-0018
Parker G; Malhi GS; Hamilton A; Morris G; Tavella G; Bassett D; Baune BT; Boyce P; Hopwood M; Mulder R; Porter R; Outhred T; Das P; Singh AB, 2019, 'Stepwise treatment of acute bipolar depression', Bipolar Disorders, 21, pp. 465 - 469, http://dx.doi.org/10.1111/bdi.12780
Parker G; Ricciardi T, 2019, 'The risk of suicide and self-harm in adolescents is influenced by the "type" of mood disorder', Journal of Nervous and Mental Disease, 207, pp. 1 - 5, http://dx.doi.org/10.1097/NMD.0000000000000917
Vollmer-Conna U; Huang S; Macnamara C; Beilharz J; Imants P; Cvejic E; Parker G, 2019, 'The mental health and wellbeing of medical trainees - autonomic, immunological and behavioural considerations', BRAIN BEHAVIOR AND IMMUNITY, 76, pp. E8 - E9, http://dx.doi.org/10.1016/j.bbi.2018.11.197
Parker G; Tavella G, 2018, 'Disruptive Mood Dysregulation Disorder: A Critical Perspective', Canadian Journal of Psychiatry, 63, pp. 813 - 815, http://dx.doi.org/10.1177/0706743718789900
Parker G; Tavella G; Macqueen G; Berk M; Grunze H; Deckersbach T; Dunner DL; Sajatovic M; Amsterdam JD; Ketter TA; Yatham LN; Kessing LV; Bassett D; Zimmerman M; Fountoulakis KN; Duffy A; Alda M; Calkin C; Sharma V; Anand A; Singh MK; Hajek T; Boyce P; Frey BN; Castle DJ; Young AH; Vieta E; Rybakowski JK; Swartz HA; Schaffer A; Murray G; Bayes A; Lam RW; Bora E; Post RM; Ostacher MJ; Lafer B; Cleare AJ; Burdick KE; O’Donovan C; Ortiz A; Henry C; Kanba S; Rosenblat JD; Parikh SV; Bond DJ; Grunebaum MF; Frangou S; Goldberg JF; Orum M; Osser DN; Frye MA; McIntyre RS; Fagiolini A; Manicavasagar V; Carlson GA; Malhi GS, 2018, 'Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project', Australian and New Zealand Journal of Psychiatry, 52, pp. 1173 - 1182, http://dx.doi.org/10.1177/0004867418808382
Parker G, 2018, 'Risks associated with lamotrigine prescription: a review and personal observations', Australasian Psychiatry, 26, pp. 640 - 642, http://dx.doi.org/10.1177/1039856218760733
Parker G; McCraw S; Tavella G; Hadzi-Pavlovic D, 2018, 'Measuring the consequences of a bipolar or unipolar mood disorder and the immediate and ongoing impacts.', Psychiatry Research, 269, pp. 70 - 74, http://dx.doi.org/10.1016/j.psychres.2018.08.022
Parker G; Smith IG; Paterson A; Romano M; Hadzi-Pavlovic D; Ricciardi T, 2018, 'How well does a wellbeing measure predict psychiatric ‘caseness’ as well as suicide risk and self-harm in adolescents?', Psychiatry Research, 268, pp. 323 - 327, http://dx.doi.org/10.1016/j.psychres.2018.07.034
Alghowinem S; Goecke R; Wagner M; Epps J; Hyett M; Parker G; Breakspear M, 2018, 'Multimodal Depression Detection: Fusion Analysis of Paralinguistic, Head Pose and Eye Gaze Behaviors', IEEE Transactions on Affective Computing, 9, pp. 478 - 490, http://dx.doi.org/10.1109/TAFFC.2016.2634527
Parker G; McCraw S; Bayes A, 2018, 'Borderline personality disorder: does its clinical features show specificity to differing developmental risk factors?', Australasian Psychiatry, 26, pp. 410 - 413, http://dx.doi.org/10.1177/1039856218760732
Parker GB; Romano M; Graham RK; Ricciardi T, 2018, 'Comparative familial aggregation of bipolar disorder in patients with bipolar I and bipolar II disorders', Australasian Psychiatry, 26, pp. 414 - 416, http://dx.doi.org/10.1177/1039856218772249
Parker G, 2018, 'Debate on Canadian Network for Mood and Anxiety Treatment (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorders', Bipolar Disorders, 20, pp. 417 - 418, http://dx.doi.org/10.1111/bdi.12661
Parker G; Paterson A; Romano M; Granville Smith I, 2018, 'Suprasensory phenomena in those with a bipolar disorder', Australasian Psychiatry, 26, pp. 384 - 387, http://dx.doi.org/10.1177/1039856218762306
Parker G, 2018, 'The benefits of antidepressants: News or fake news?', British Journal of Psychiatry, 213, pp. 454 - 455, http://dx.doi.org/10.1192/bjp.2018.98
Macnamara CL; Cvejic E; Parker GB; Lloyd AR; Lee G; Beilharz JE; Vollmer-Conna U, 2018, 'Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: Study protocol for a randomised controlled trial', Trials, 19, pp. 371, http://dx.doi.org/10.1186/s13063-018-2763-8
Malhi GS; Porter R; Irwin L; Hamilton A; Morris G; Bassett D; Baune BT; Boyce P; Hopwood MJ; Mulder R; Parker G; Mannie Z; Outhred T; Das P; Singh AB, 2018, 'Defining a mood stabiliser: Novel framework for research and clinical practice', BJPsych Open, 4, pp. 278 - 281, http://dx.doi.org/10.1192/bjo.2018.36
Bayes AJ; Parker GB, 2018, 'Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation', Acta Psychiatrica Scandinavica, 137, pp. 459 - 471, http://dx.doi.org/10.1111/acps.12878
Bayes A; Graham RK; Parker GB; McCraw S, 2018, 'Is 'subthreshold’ bipolar II disorder more difficult to differentiate from borderline personality disorder than formal bipolar II disorder?', Psychiatry Research, 264, pp. 416 - 420, http://dx.doi.org/10.1016/j.psychres.2018.04.018
Parker GB, 2018, 'FIFO, FIFO, and off to work we woe', Medical Journal of Australia, 208, pp. 388 - 389, http://dx.doi.org/10.5694/mja18.00075
Berk M; Boyce P; Hamilton A; Morris G; Outhred T; Das P; Bassett D; Baune BT; Lyndon B; Mulder R; Parker G; Singh AB; Malhi GS, 2018, 'Personality: Distraction or driver in the diagnosis of depression', Personality and Mental Health, 12, pp. 126 - 130, http://dx.doi.org/10.1002/pmh.1411
Parker G, 2018, 'Psychotropic Drug Intolerance', Journal of Nervous and Mental Disease, 206, pp. 223 - 225, http://dx.doi.org/10.1097/NMD.0000000000000787
Hyett MP; Perry A; Breakspear M; Wen W; Parker GB, 2018, 'White matter alterations in the internal capsule and psychomotor impairment in melancholic depression', PLoS ONE, 13, pp. e0195672, http://dx.doi.org/10.1371/journal.pone.0195672
Parker GB; Tavella G, 2018, 'Design limitations to bipolar II treatment efficacy studies: A challenge and a revisionist strategy', Journal of Affective Disorders, 229, pp. 334 - 341, http://dx.doi.org/10.1016/j.jad.2017.12.072
Graham RK; Tavella G; Parker GB, 2018, 'Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?', Journal of Affective Disorders, 228, pp. 216 - 221, http://dx.doi.org/10.1016/j.jad.2017.12.022
Mulder R; Singh AB; Hamilton A; Das P; Outhred T; Morris G; Bassett D; Baune BT; Berk M; Boyce P; Lyndon B; Parker G; Malhi GS, 2018, 'The limitations of using randomised controlled trials as a basis for developing treatment guidelines', Evidence-Based Mental Health, 21, pp. 4 - 6, http://dx.doi.org/10.1136/eb-2017-102701
Parker G, 2018, 'Thinking fast and slow – in clinical psychiatry', Acta Psychiatrica Scandinavica, 137, pp. 85 - 87, http://dx.doi.org/10.1111/acps.12837
Bassett D; Parker G, 2018, 'Tinkering at the margins: A response to Chanen', Bipolar Disorders, 20, pp. 76, http://dx.doi.org/10.1111/bdi.12573